IBDEI0IX ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8797,1,4,0)
 ;;=4^H11.443
 ;;^UTILITY(U,$J,358.3,8797,2)
 ;;=^5004799
 ;;^UTILITY(U,$J,358.3,8798,0)
 ;;=H11.33^^41^468^38
 ;;^UTILITY(U,$J,358.3,8798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8798,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Bilateral
 ;;^UTILITY(U,$J,358.3,8798,1,4,0)
 ;;=4^H11.33
 ;;^UTILITY(U,$J,358.3,8798,2)
 ;;=^5004784
 ;;^UTILITY(U,$J,358.3,8799,0)
 ;;=H10.403^^41^468^44
 ;;^UTILITY(U,$J,358.3,8799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8799,1,3,0)
 ;;=3^Conjunctivitis,Bilateral,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,8799,1,4,0)
 ;;=4^H10.403
 ;;^UTILITY(U,$J,358.3,8799,2)
 ;;=^5004683
 ;;^UTILITY(U,$J,358.3,8800,0)
 ;;=H10.33^^41^468^41
 ;;^UTILITY(U,$J,358.3,8800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8800,1,3,0)
 ;;=3^Conjunctivitis,Acute,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,8800,1,4,0)
 ;;=4^H10.33
 ;;^UTILITY(U,$J,358.3,8800,2)
 ;;=^5004680
 ;;^UTILITY(U,$J,358.3,8801,0)
 ;;=H18.003^^41^468^50
 ;;^UTILITY(U,$J,358.3,8801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8801,1,3,0)
 ;;=3^Corneal Desposit,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,8801,1,4,0)
 ;;=4^H18.003
 ;;^UTILITY(U,$J,358.3,8801,2)
 ;;=^5005006
 ;;^UTILITY(U,$J,358.3,8802,0)
 ;;=H16.403^^41^468^52
 ;;^UTILITY(U,$J,358.3,8802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8802,1,3,0)
 ;;=3^Corneal Neovascularization,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,8802,1,4,0)
 ;;=4^H16.403
 ;;^UTILITY(U,$J,358.3,8802,2)
 ;;=^5004967
 ;;^UTILITY(U,$J,358.3,8803,0)
 ;;=H15.103^^41^468^62
 ;;^UTILITY(U,$J,358.3,8803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8803,1,3,0)
 ;;=3^Episcleritis,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,8803,1,4,0)
 ;;=4^H15.103
 ;;^UTILITY(U,$J,358.3,8803,2)
 ;;=^5004837
 ;;^UTILITY(U,$J,358.3,8804,0)
 ;;=H16.213^^41^468^65
 ;;^UTILITY(U,$J,358.3,8804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8804,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,Bilateral
 ;;^UTILITY(U,$J,358.3,8804,1,4,0)
 ;;=4^H16.213
 ;;^UTILITY(U,$J,358.3,8804,2)
 ;;=^5004922
 ;;^UTILITY(U,$J,358.3,8805,0)
 ;;=H16.123^^41^468^73
 ;;^UTILITY(U,$J,358.3,8805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8805,1,3,0)
 ;;=3^Filamentary Keratitis,Bilateral
 ;;^UTILITY(U,$J,358.3,8805,1,4,0)
 ;;=4^H16.123
 ;;^UTILITY(U,$J,358.3,8805,2)
 ;;=^5004907
 ;;^UTILITY(U,$J,358.3,8806,0)
 ;;=H10.413^^41^468^77
 ;;^UTILITY(U,$J,358.3,8806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8806,1,3,0)
 ;;=3^Giant Papillary Conjunctivitis,Bilateral,Chronic
 ;;^UTILITY(U,$J,358.3,8806,1,4,0)
 ;;=4^H10.413
 ;;^UTILITY(U,$J,358.3,8806,2)
 ;;=^5004686
 ;;^UTILITY(U,$J,358.3,8807,0)
 ;;=H21.03^^41^468^83
 ;;^UTILITY(U,$J,358.3,8807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8807,1,3,0)
 ;;=3^Hyphema,Bilateral
 ;;^UTILITY(U,$J,358.3,8807,1,4,0)
 ;;=4^H21.03
 ;;^UTILITY(U,$J,358.3,8807,2)
 ;;=^5005174
 ;;^UTILITY(U,$J,358.3,8808,0)
 ;;=H20.053^^41^468^86
 ;;^UTILITY(U,$J,358.3,8808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8808,1,3,0)
 ;;=3^Hypopyon,Bilateral
 ;;^UTILITY(U,$J,358.3,8808,1,4,0)
 ;;=4^H20.053
 ;;^UTILITY(U,$J,358.3,8808,2)
 ;;=^5005152
 ;;^UTILITY(U,$J,358.3,8809,0)
 ;;=H21.263^^41^468^92
 ;;^UTILITY(U,$J,358.3,8809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8809,1,3,0)
 ;;=3^Iris Atrophy,Bilateral
 ;;^UTILITY(U,$J,358.3,8809,1,4,0)
 ;;=4^H21.263
 ;;^UTILITY(U,$J,358.3,8809,2)
 ;;=^5005201
 ;;^UTILITY(U,$J,358.3,8810,0)
 ;;=H16.293^^41^468^98
 ;;^UTILITY(U,$J,358.3,8810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8810,1,3,0)
 ;;=3^Keratoconjunctivitis,Bilateral NEC
 ;;^UTILITY(U,$J,358.3,8810,1,4,0)
 ;;=4^H16.293
